ChoA Pharmaceutical Co.Ltd (034940) — Cash Flow-to-Debt Ratio
ChoA Pharmaceutical Co.Ltd (034940) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2026, meaning its operating cash flow of ₩-2.41 Billion could theoretically repay 0% of its total liabilities (₩41.42 Billion) in one year. Explore ChoA Pharmaceutical Co.Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ChoA Pharmaceutical Co.Ltd Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for ChoA Pharmaceutical Co.Ltd across 14 annual periods. Also explore 034940 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ChoA Pharmaceutical Co.Ltd (2004–2025)
Year-by-year debt coverage analysis for ChoA Pharmaceutical Co.Ltd. For market capitalisation and broader financial context, see market cap of ChoA Pharmaceutical Co.Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | ₩-4.18 Billion | ₩42.92 Billion | ▲ +12.9% |
| 2024 | -0.11x | ₩-4.47 Billion | ₩39.94 Billion | ▼ -168.9% |
| 2023 | -0.04x | ₩-1.48 Billion | ₩35.46 Billion | ▲ +5.5% |
| 2022 | -0.04x | ₩-1.44 Billion | ₩32.80 Billion | ▲ +9.1% |
| 2021 | -0.05x | ₩-1.48 Billion | ₩30.59 Billion | ▼ -160.6% |
| 2020 | 0.08x | ₩1.92 Billion | ₩24.07 Billion | ▼ -35.3% |
| 2019 | 0.12x | ₩4.16 Billion | ₩33.69 Billion | ▲ +81.5% |
| 2018 | 0.07x | ₩2.04 Billion | ₩30.08 Billion | ▲ +395.3% |
| 2017 | -0.02x | ₩-675.51 Million | ₩29.34 Billion | ▼ -167.4% |
| 2016 | 0.03x | ₩930.42 Million | ₩27.26 Billion | ▼ -21.8% |
| 2015 | 0.04x | ₩1.19 Billion | ₩27.19 Billion | ▲ +95.1% |
| 2014 | 0.02x | ₩625.52 Million | ₩27.96 Billion | ▼ -87.2% |
| 2013 | 0.17x | ₩3.53 Billion | ₩20.19 Billion | ▲ +6.6% |
| 2004 | 0.16x | ₩3.57 Billion | ₩21.78 Billion | — |